Majkowski Serves as Patient Representative

May 30, 2017

Paul Majkowski recently sat on a panel of the U.S. Food & Drug Administration’s Oncologic Drugs Advisory Committee. His role was patient representative.

The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer and makes appropriate recommendations to the Commissioner of Food and Drugs.

Legal updates and news delivered to your inbox